All News #Library
Biotech
Pharvaris Reports 2025 Financial Results And Business Update
02 Apr 2026 //
GLOBENEWSWIRE
Lancet Haematology Publishes Deucrictibant Efficacy, Safety Data
20 Mar 2026 //
GLOBENEWSWIRE
Clinical Reviews Publishes PRO Validation for HAE Attacks
11 Mar 2026 //
GLOBENEWSWIRE
Deucrictibant Shows Promise in Bradykinin Angioedema Treatment
02 Mar 2026 //
GLOBENEWSWIRE
Pharvaris to Present Clinical Data at AAAAI 2026 Annual Meeting
10 Feb 2026 //
GLOBENEWSWIRE
Pharvaris Outlines 2026 Strategic Priorities
12 Jan 2026 //
GLOBENEWSWIRE
Pharvaris To Present Clinical Data At ACAAI 2025 Conference
23 Oct 2025 //
GLOBENEWSWIRE
Pharvaris Upsizes Public Offering to $175M with Shares & Warrants
22 Jul 2025 //
GLOBENEWSWIRE
Pharvaris Outlines 2025 Strategic Priorities
13 Jan 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support